Asthma remission in patients with eosinophilic granulomatosis with polyangiitis (EGPA) following treatment with benralizumab or mepolizumab

被引：0
|
作者：
Bourdin, A. [1 ]
Wechsler, M. E. [2 ]
Jackson, D. J. [3 ]
Siddiqu, S. [4 ]
Baudy, P. [5 ]
Menzies-Gow, A. [6 ]
Shavit, A. [7 ]
Necander, S. [8 ]
Walton, C. [9 ]
机构：
[1] Univ Montpellier, CHU Montpellier, Dept Resp Dis, INSERM, Montpellier, France
[2] Natl Jewish Hlth, Dept Med, Denver, CO USA
[3] Kings Coll London, Guys Severe Asthma Ctr, London, England
[4] Imperial Coll London, Hammersmith & Royal Brompton Hosp, Natl Heart & Lung Inst, London, England
[5] AstraZeneca, Resp & Immunol US Med, Wilmington, DE USA
[6] AstraZeneca, BioPharmaceut Med Resp & Immunol, Cambride, England
[7] AstraZeneca, BioPharmaceut R&D, Late Stage Resp & Immunol, Cambridge, England
[8] AstraZeneca, Late Stage Resp & Immunol, BioPharmaceut R&D, Gothenburg, Sweden
[9] AstraZeneca, Late Stage Resp & Immunol, BioPharmaceut R&D, Cambride, England
来源：
ALLERGOLOGIE | 2024年 / 47卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P3.5
引用
收藏
页数：55
相关论文
共 50 条
  • [1] Asthma remission in patients with eosinophilic granulomatosis with polyangiitis (EGPA) following treatment with benralizumab or mepolizumab
    Bourdin, Arnaud
    Wechsler, Michael E.
    Jackson, David J.
    Siddiqui, Salman
    Baudy, Peter
    Menzies-Gow, Andrew
    Necander, Sofia
    Shavit, Anat
    Walton, Claire
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [2] Complete Remission in Eosinophilic Granulomatosis with Polyangiitis (EGPA) in the MANDARA Trial of Benralizumab vs Mepolizumab
    Wechsler, M. E.
    Agmon-Levin, N.
    Jayne, D. R. W.
    Pagnoux, C.
    Specks, U.
    Sjo, L. Borjesson
    Necander, S.
    Shavit, A.
    Walton, C.
    Merkel, P. A.
    Worner, P.
    SWISS MEDICAL WEEKLY, 2024, 154 : 5S - 5S
  • [3] Evaluation of mepolizumab (MPZ) treatment in Eosinophilic Granulomatosis with Polyangiitis (EGPA) patients in an asthma clinic
    Lopez, Laura Castellanos
    Serrano, Carolina Cisneros
    Marcos, Maria Celeste
    Garcia, Marta Solis
    Hernandez, Ana Sofia Martin
    Menendez, Mateo Hevia
    Garcia, Ana Arcos
    Pelaez-Laderas, Adrian
    Moreno, Carlos Melero
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [4] Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis
    Desaintjean, Charlene
    Ahmad, Kais
    Traclet, Julie
    Gerfaud-Valentin, Mathieu
    Durel, Cecile-Audrey
    Glerant, Jean-Charles
    Hot, Arnaud
    Lestelle, Francois
    Mainbourg, Sabine
    Nasser, Mouhamad
    Seve, Pascal
    Turquier, Segolene
    Devouassoux, Gilles
    Cottin, Vincent
    FRONTIERS IN MEDICINE, 2024, 11
  • [5] EFFICACY OF BENRALIZUMAB AND MEPOLIZUMAB ON ASTHMA OUTCOMES IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
    Wechsler, M.
    Bourdin, A.
    Chanez, P.
    Jackson, D.
    Siddiqui, S.
    Specks, U.
    Baudy, P.
    Necander, S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S49 - S50
  • [6] Therapeutic Success with Mepolizumab for the Treatment of eosinophilic Granulomatosis with Polyangiitis (EGPA)
    Bauer, Julia
    Grabbe, Stephan
    Stege, Helger
    Lang, Berenice
    Rogall, Friederike
    Klumpp, Annika
    Tsochataridou, Aikaterini
    Joachim, Saloga
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 76 - 77
  • [7] Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis
    Wechsler, Michael E.
    Nair, Parameswaran
    Terrier, Benjamin
    Walz, Bastian
    Bourdin, Arnaud
    Jayne, David R. W.
    Jackson, David J.
    Roufosse, Florence
    Boerjesson Sjoe, Lena
    Fan, Ying
    Jison, Maria
    Mccrae, Christopher
    Necander, Sofia
    Shavit, Anat
    Walton, Claire
    Merkel, Peter A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (10): : 911 - 921
  • [8] Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis
    Sun, Ryan
    Wei, Lee-Jen
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (20):
  • [9] Complete Remission in Eosinophilic Granulomatosis with Polyangiitis in the MANDARA Trial of Benralizumab versus Mepolizumab
    Wechsler, M. E.
    Agmon-Levin, N.
    Jayne, D. R. W.
    Pagnoux, C.
    Specks, U.
    Sjo, Borjesson L.
    Necander, S.
    Shavit, A.
    Walton, C.
    Merkel, P. A.
    SWISS MEDICAL WEEKLY, 2024, 154 : 33S - 33S
  • [10] Mepolizumab and Benralizumab: new therapeutic perspectives for Severe Eosinophilic Asthma and Eosinophilic Granulomatosis with Polyangiitis
    Scarano, Paola
    Cisternino, Cecilia
    Lo Muzio, Giulia
    Calo, Olimpia
    Sanna, Arianna
    Steffanina, Alessia
    De Filippis, Francesca
    Leporini, Maria Teresa
    Palange, Paolo
    Graziani, Elda
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
12345